Lookup NU author(s): Dr Sarah Johnson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Calcitonin-negative medullary thyroid carcinoma is a rare, poorly understood primary neuroendocrine carcinoma of the thyroid characterised by classic medullary thyroid carcinoma morphology without raised serum calcitonin. A 24-year-old woman presented with a slow-growing, right-sided neck swelling. She underwent an ultrasound scan, cytopathological and histopathological examination, and tests for alternative diagnoses. The ultrasound showed a heterogeneous, hyperechoic nodule in the right thyroid lobe. Serum calcitonin was normal. Cytopathology and histopathology showed typical medullary thyroid carcinoma morphology but without calcitonin upon immunostaining and mRNA in situ hybridisation. A 'triple-negative' calcitonin-negative medullary thyroid carcinoma was diagnosed. A completion thyroidectomy with bilateral central lymph node dissection was performed. The patient remains well three-years post-surgery. When cytopathology suggests a medullary thyroid carcinoma, serum calcitonin, pro-calcitonin, carcinoembryonic antigen and calcitonin-gene-related peptide should be measured to identify cases of calcitonin-negative medullary thyroid carcinoma. They should also be measured post-treatment for monitoring purposes. This will aid future calcitonin-negative medullary thyroid carcinoma diagnoses and will inform prognostic stratification and influence treatment decisions.
Author(s): Murphy DC, Johnson SJ, Aspinall S
Publication type: Article
Publication status: Published
Journal: Annals of the Royal College of Surgeons of England
Print publication date: 01/03/2020
Online publication date: 16/12/2019
Acceptance date: 02/04/2016
ISSN (print): 0035-8843
ISSN (electronic): 1478-7083
Publisher: Royal College of Surgeons of England
PubMed id: 31841033
Altmetrics provided by Altmetric